Nurika Narynbekovna Assanzhanova

Dr. Nurika Narynbekovna Assanzhanova

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2022 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
ANAinur Nurpeisova
Ainur Nurpeisova
BKBerik Khairullin
Berik Khairullin
RARuslan Abitayev
Ruslan Abitayev
KSKamshat Shorayeva
Kamshat Shorayeva
KJKuanysh Jekebekov
Kuanysh Jekebekov
KZKunsulu Zakarya
Kunsulu Zakarya
This article describes the results of a preclinical safety and immunogenicity study of QazCovid-in®, the first COVID-19 vaccine developed in Kazakhstan, on BALB/c mice, rats, ferrets, Syrian hamsters and rhesus macaques (Macaca mulatta). The study’s safety data suggests that this immunobiological preparation can be technically considered a Class 5 nontoxic vaccine. The series of injections that were made did not produce any adverse effect or any change in the general condition of the model animals’ health, while macroscopy and histology studies identified no changes in the internal organs of the BALB/c mice and rats. This study has demonstrated that a double immunization enhances the growth of antibody titers as assessed by the microneutralization assay (MNA) and the enzyme-linked immunosorbent assay (ELISA) in a pre-clinical immunogenicity test on animal models. The best GMT results were assessed in MNA and ELISA 7 days after re-vaccination; however, we noted that GMT antibody results in ELISA were lower than in MNA. A comparative GMT assessment after the first immunization and the re-immunization identified significant differences between model animal groups and a growth of GMT antibodies in all of them; also, differences between the gender groups were statistically significant. Moreover, the most marked MNA immune response to the QazCovid-in® vaccine was seen in the Syrian hamsters, while their SARS-CoV-2-specific antibody activity as assessed with ELISA was the lowest.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DBDina Bugybayeva
Dina Bugybayeva
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
NZNadezhda Zinina
Nadezhda Zinina
MSMakhpal Sarmykova
Makhpal Sarmykova
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
KTKaissar Tabynov
Kaissar Tabynov
In this paper, we first used recombinant influenza viral vector (rIVV) subtype H5N1 expressing from the open reading frame of NS1 80 and NS1 124 amino acids of Brucella outer membrane proteins (Omp) 16 and 19, ribosomal L7/L12, and Cu‐Zn superoxide dismutase (SOD) proteins to develop a human brucellosis vaccine. We made 18 combinations of IVVs in mono‐, bi‐, and tetravalent vaccine formulations and tested them on mice to select the safest and most effective vaccine samples. Then, the most effective vaccine candidates were further tested on guinea pigs. Safety of the rIVV‐based vaccine candidate was evaluated by a mouse weight‐gain test. Mice and guinea pigs were challenged with the virulent strain B. melitensis 16M. The protective effect of the rIVV‐based vaccine candidate was assessed by quantitation of Brucella colonization in tissues and organs of challenged animals. All vaccine formulations were safe in mice. Tested vaccine formulations, as well as the commercial B. melitensis Rev.1 vaccine, have been found to protect mice from B. melitensis 16M infection within the range of 1.6 to 2.97 log10 units (P < 0.05). Tetravalent vaccine formulations from the position of NS1 80 amino acids (0.2 ± 0.4), as well as the commercial B. melitensis Rev.1 vaccine (1.2 ± 2.6), have been found to protect guinea pigs from B. melitensis 16M infection at a significant level (P < 0.05). Thus, tetravalent vaccine formulation Flu‐NS1‐80‐Omp16+Flu‐NS1‐80‐L7/L12+Flu‐NS1‐80‐Omp19+Flu‐NS1‐80‐SOD was chosen as a potential vaccine candidate for further development of an effective human vaccine against brucellosis. These results show a promising future for the development of a safe human vaccine against brucellosis based on rIVVs.

1 May 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
OCOlga Chervyakova
Olga Chervyakova
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
AMAigerim Mailybayeva
Aigerim Mailybayeva
Brucellosis remains one of the most widespread zoonotic infections worldwide, causing serious veterinary, medical, and socio-economic consequences. The disease, caused by bacteria of the genus Brucella, affects a wide range of domestic and wild animals as well as humans, with global incidence potentially reaching 1.6–2.1 million new cases annually. The most effective approach to combating brucellosis is specific prevention through vaccination. Therefore, we conducted this review to summarize data from existing studies on modern strategies for brucellosis vaccination, types of vaccine platforms, their efficacy, safety, and applicability in veterinary and human medicine. We searched databases including PubMed, Scopus, and Web of Science to identify relevant scientific articles in English published from 1990 to 2025. The aim of this work is to conduct a systematic analysis of modern brucellosis vaccination strategies in livestock and humans, as well as to evaluate the prospects of new vaccine platforms. The review examines live attenuated, inactivated, subunit, vector, and DNA vaccines, as well as their immunological mechanisms of action, advantages, and limitations of application. This information allows for a better understanding of the mechanisms of protective immunity formation and challenges related to DIVA diagnostics (Differentiating Infected from Vaccinated Animals). The “One Health” concept demonstrated the interconnection between human, animal, and environmental factors, emphasizing the need for an interdisciplinary approach to brucellosis monitoring, prevention, and control. Vector vaccines based on influenza virus (Flu-BA), developed in Kazakhstan, have shown high promise, combining immunogenicity, protective efficacy, and a favorable safety profile. Promising directions remain mRNA vaccines, nanoparticles, CRISPR/Cas9 technologies, and mucosal vaccines.

28 November 2025 in Plants
Verified
Journal Article
Open access
PDF file
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NTNasya TOMLEKOVA
Nasya TOMLEKOVA
GSGalymzhan Saparov
Galymzhan Saparov
YAYergali Abduraimov
Yergali Abduraimov
AKAslan Kerimbaev
Aslan Kerimbaev
BABakytzhan Anapiyayev
Bakytzhan Anapiyayev
Soil contamination with heavy metals is a persistent challenge in the arid regions of Kazakhstan. This study evaluates the phytoremediation potential of sweet sorghum (Sorghum bicolor L.), a drought-tolerant crop with a well-developed root system, using a combination of in vitro and analytical approaches. In vitro culture of somatic cells revealed clear genotype-dependent differences in callus induction and morphogenesis, with Hybrid-2 and SAB-3 exhibiting the highest regenerative capacity and thus the greatest suitability for further biotechnological improvement and stress-tolerance selection. Analysis of metal distribution, based on atomic absorption spectroscopy (AAS), demonstrated that S. bicolor predominantly retained Pb, Cd, and Co in the root system. Cobalt accumulated to 12.7 ± 1.32 mg/kg under 1 MAC and 16.87 ± 2.78 mg/kg under 2 MAC, accounting for more than half of the metal absorbed by plants. Cadmium showed a similar root-dominant pattern, whereas lead exhibited the lowest mobility and remained almost entirely sequestered in roots, with translocation factors consistently below unity (TF < 1). Overall, these findings confirm the suitability of sweet sorghum as an environmentally sustainable species for the phytostabilization of Pb-, Cd-, and Co-contaminated soils in arid environments and highlight the value of genotype pre-selection under stress conditions for optimizing phytoremediation performance.

23 April 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
AMAigerim Mailybayeva
Aigerim Mailybayeva
EKErken Kozhamkulov
Erken Kozhamkulov
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
Background/Objectives: Despite the availability of Newcastle disease (ND) vaccines, outbreaks have continued to occur for more than six decades, with significant economic consequences for the global poultry industry. The variability of the Newcastle disease virus requires constant monitoring, detection of new cases, and studies of the origin of the pathogen. The aim of this study was to develop an inactivated ND vaccine using a topical strain with different adjuvants and to compare them for stability, harmlessness, immunogenicity, and efficacy. Methods: A phylogenetic study of the F-gene of the ND strain isolated in Kazakhstan was conducted. The strain, which was selected to create a vaccine for the prevention of the disease, was revealed to belong to genotype VII class II and uploaded to GenBank (NCBI). Two different adjuvants, Montanide ISA 70 VG and Montanide ISA 78 VG, were used to create the vaccine. Birds were vaccinated intramuscularly. Results: Evaluations of antibody titers in the vaccinated groups during the experiment showed that the vaccines induced adequate levels of antibodies to provide protection against the virulent virus. High antibody titers were observed in the hemagglutination inhibition assay (HAI) in the vaccinated groups as early as 14 days post-vaccination in 100% of birds. The average antibody titer in both vaccinated groups exceeded 7 log2, sufficient to prevent clinical signs. None of the vaccinated birds exhibited clinical signs following control infection, whereas unvaccinated birds developed clinical manifestations within three days post-infection, leading to 100% mortality. Conclusions: The vaccine developed using the epizootic topical strain is stable, harmless, immunogenic, and effective when challenged with a virulent ND virus strain at a dose of 105 EID50/mL.

22 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NTNasya TOMLEKOVA
Nasya TOMLEKOVA
GSGalymzhan Saparov
Galymzhan Saparov
EAE. O. Abduraimov
E. O. Abduraimov
AKAslan Kerimbaev
Aslan Kerimbaev
BABakytzhan B. Anapiyayev
Bakytzhan B. Anapiyayev
In recent years, soil contamination with heavy metals—such as plumbum, cadmium, and cobalt—has become an increasingly pressing environmental issue due to the rapid expansion of industry, transportation, and urbanization. These elements are non-biodegradable, gradually accumulate along trophic chains, and can ultimately exert serious adverse effects on human health. In this study, we focused on sweet sorghum (Sorghum bicolor L.) as a promising candidate for phytoremediation of heavy metal–contaminated soils. Both field and laboratory approaches were employed: in vitro culture of somatic cells was used to select stress-tolerant and high-yielding genotypes, while atomic absorption spectroscopy (AAS) was applied to quantify heavy metal concentrations in soil and plant tissues. Experimental results demonstrated that callus induction frequency was strongly genotype-dependent. The highest callus formation rates were observed in Hybrid-2 (69.11%), SAB-3 (43.83%), SABB-1 (42.31%), and SAB-10 (40.32%). Among these, Hybrid-2 (27.94%) and SAB-3 (23.28%) also exhibited the highest frequencies of morphogenic callus formation, confirming their suitability for subsequent micropropagation and cell-based selection. Particular attention was paid to the distribution of toxicants among plant organs. The rate and direction of metal translocation from roots to shoots were found to critically influence the efficiency of subsequent metal removal, as stems constitute the major component of easily harvestable biomass. Nevertheless, a substantial proportion of heavy metals remained sequestered in the roots: cobalt concentrations reached 12.7 ± 1.32 mg/kg at 1 MPC (Maximum Permissible Concentration) and 16.87 ± 2.78 mg/kg at 2 MPC, accounting for more than 50% of the total accumulated amount. Similar trends were observed for cadmium (~49%) and plumbum (up to 53%). Thus, our findings underscore the pivotal role of genotype in in vitro callus formation and morphogenesis, and further highlight the potential of sweet sorghum as an effective phytoremediation agent for reclaiming heavy metal–contaminated lands, particularly in arid regions.